The RNA (yellow) of the SARS-CoV-2 virus forms a pseudoknot structure (multicolored, bottom right) which leads to a shift in the reading frame of the ribosome (brown). In this way, the viral RNA controls the production levels of the viral proteins.
Graphic: Said Sannuga, Cellscape.co.uk / ETH Zurich, The Ban Lab
Researchers at the federal technology institute ETH Zurich have discovered an important weak point of Covid-19: if a key process for the production of its proteins is disrupted, viral replication in infected cells can be significantly reduced.
This content was published on
3 minutes
Keystone-SDA/ts
Português
pt
Cientistas suíços descobrem o calcanhar de Aquiles do coronavírus
This discovery, which they described as the “Achilles heel of the coronavirus”, may lead to the development of antiviral drugs that can also treat more distantly related coronaviruses.
The magic word is “frameshifting”. During the step-by-step reading of the blueprint from ribonucleic acid (RNA), the ribosome (the cell’s own protein factory) occasionally “miscounts” and omits letters. This rarely happens in healthy cells, because an incorrectly read and copied sequence results in dysfunctional proteins.
However, certain viruses such as coronaviruses or HIV rely on such shifts in the reading frame to regulate the production of their proteins. The SARS-CoV-2 virus, which causes Covid-19, induces frameshifting by folding its RNA in an unusual and complex manner, the research team wrote in a statementExternal link on Thursday.
External Content
“Therefore, since frameshifting is essential for the virus but it almost never happens in our organism, any compound that inhibits frameshifting by targeting this RNA fold could potentially be useful as a drug to combat infection,” they stated.
Until now there has been a lack of precise information about the interaction of the viral RNA with the ribosome of the infected host cell during frameshifting. But researchers at ETH Zurich and the Universities of Bern, Lausanne and Cork (Ireland) have now succeeded in observing this process, they explain in the latest issue of the journal ScienceExternal link.
Chemical compounds
Using sophisticated biochemical experiments, they were able to capture the ribosome at the frameshifting site of the SARS-CoV-2 RNA. The scientists were then able to examine this molecular complex using cryo-electron microscopyExternal link.
They also went a step further and tried to specifically influence the process with chemical substances. They found two chemical compounds that reduce viral replication by 1,000 to 10,000 times – without being toxic for the cells treated with them.
They said that although these compounds were currently not potent enough to be used as therapeutic drugs, the study demonstrated that inhibition of ribosomal frameshifting had a profound effect on viral replication. This paves the way for the development of better compounds that could eventually be used in the treatment of all coronaviruses.
“Our future work will focus on understanding the cellular defence mechanisms that suppress viral frameshifting, as this could be useful for development of small compounds with similar activity,” said Nenad Ban, Professor of Molecular Biology at ETH Zurich and co-author of the study.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
This content was published on
The Swiss Broadcasting Corporation (SBC), Swissinfo's parent company, must restructure due to financial pressures and to stay competitive in the fast-moving media environment.
This content was published on
There has been a sharp decline in the consumption of single-use disposable plastic bags and reusable plastic bags in the Swiss retail sector.
This content was published on
A biometric Swiss identity card (ID) is expected to be available in Switzerland by the end of 2026. The Federal Office of Police and its federal and cantonal partners are working on a new ID card that features a chip.
Heatwave reduces output at Swiss nuclear power plant by 50%
This content was published on
The ongoing heatwave has forced the Beznau nuclear power plant, which relies on water from the River Aare, to halve its output.
Swiss continue to enjoy high social mobility, study shows
This content was published on
Opportunities for upward social mobility have remained intact in Switzerland since the 1980s. Social mobility is exceptionally high by international comparison, a study shows.
Swiss government affected by cyberattack on health foundation
This content was published on
Switzerland says a ransomware attack on the non-profit health foundation Radix that involved data being stolen and encrypted had also affected the federal administration.
Federal Council agrees to investigation into alleged Swiss-Russian spying affair
This content was published on
The Office of the Attorney General of Switzerland can open spying investigations into the Swiss Federal Intelligence Service (FIS).
Appeal launched against Starlink satellite antennae project planned in Swiss village
This content was published on
A group of Swiss citizens has filed an appeal against plans to install 40 Starlink satellite antennae in the mountain village of Leuk in southern Switzerland.
UBS launches buyback scheme for up to $2 billion in shares
This content was published on
UBS is starting a share buyback programme for up to $2 billion (CHF1.6 billion) in shares, in line with a plan approved at its annual general meeting (AGM) in April, the Swiss bank said on Monday.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.